Correction: Drug-associated insomnia and sex-specific disproportionality in the FDA adverse event reporting system (2019–Q1 2025)
Frontiers in Pharmacology · 03.11.2026 · 17
DOI: 10.3389/fphar.2026.2023334 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.11.2026. Verfasst von Hao Wen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaf
Abstract (Originalsprache)
A Correction on Drug-associated insomnia and sex-specific disproportionality in the FDA adverse event reporting system (2019-Q1 2025)
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangzhou University of Chinese Medicine, Guangzhou, China.
- Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Zhuhai, China.
Zitieren
APA
Wen, H., Shen, Y., Li, H., Chen, X., Lin, Y., & Bin, W. (2026). Correction: Drug-associated insomnia and sex-specific disproportionality in the FDA adverse event reporting system (2019–Q1 2025). Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.2023334
Vancouver
Wen H, Shen Y, Li H, Chen X, Lin Y, Bin W. Correction: Drug-associated insomnia and sex-specific disproportionality in the FDA adverse event reporting system (2019–Q1 2025). Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.2023334
BibTeX
@article{Wen2026,
author = {Wen, Hao and Shen, Yuchuan and Li, Hai and Chen, Xiangbin and Lin, Yanzhao and Bin, Wei},
title = {Correction: Drug-associated insomnia and sex-specific disproportionality in the FDA adverse event reporting system (2019–Q1 2025)},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.2023334}
}
EUVIMED